GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » SCOR SE (OTCPK:SCRYY) » Definitions » Marketable Securities

SCRYY (SCOR SE) Marketable Securities : $20,905 Mil (As of Dec. 2024)


View and export this data going back to 1996. Start your Free Trial

What is SCOR SE Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. SCOR SE's Marketable Securities for the quarter that ended in Dec. 2024 was $20,905 Mil.

SCOR SE's annual Marketable Securities increased from Dec. 2022 ($19,823 Mil) to Dec. 2023 ($21,002 Mil) but then declined from Dec. 2023 ($21,002 Mil) to Dec. 2024 ($20,905 Mil).


SCOR SE Marketable Securities Historical Data

The historical data trend for SCOR SE's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SCOR SE Marketable Securities Chart

SCOR SE Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22,551.10 22,068.93 19,823.09 21,002.18 20,904.71

SCOR SE Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19,823.09 19,825.57 21,002.18 20,741.66 20,904.71

SCOR SE Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


SCOR SE  (OTCPK:SCRYY) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


SCOR SE Marketable Securities Related Terms

Thank you for viewing the detailed overview of SCOR SE's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


SCOR SE Business Description

Address
5, avenue Kleber, Paris, FRA, 75116
Scor is the world's sixth-largest reinsurer, selling nonlife and life reinsurance. Scor global life insures life insurance and annuities. This means in its co-insurance agreements Scor shares in premiums and claims of life insurance contracts that have been sold by a primary insurer. In its excess of loss agreements, Scor reimburses a primary insurer for claims that are filed above an agreed amount. Scor also sells property and casualty reinsurance in coinsurance and excess of loss. Historically, Scor has been better in specialist lines and not as good in lines where there is a large potential for loss. Having recently grown in natural catastrophe, standards of underwriting have not been good. The business has subsequently decided to move back to less volatile lines.

SCOR SE Headlines

From GuruFocus

Q1 2020 Scor SE Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2023 Scor SE Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2021 Scor SE Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2023 Scor SE Earnings Call Transcript

By GuruFocus Research 02-14-2024

Scor SE Virtual IR Day 2020 Transcript

By GuruFocus Research 02-14-2024

Scor SE Special Call Transcript

By GuruFocus Research 02-14-2024

Scor SE Investor Day (Virtual) Transcript

By GuruFocus Research 02-14-2024

Scor SE Corporate Analyst Meeting Transcript

By GuruFocus Research 02-14-2024